Physician

Dustin N Ly, MD

According to 2025 Medicare claims, Dustin Ly, MD (NPI: 1710195268) practices general practice in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is SUNSHINE OF MIAMI LAKES CORP (NPI: 1861294043) and primary practice location at 33016-1516.

Ly's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 141 traditional Medicare patients, billed 1,147 HCPCS/CPT codes, and received $67,845 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 1,974 prescription claims across 182 beneficiaries totaling $166,056 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 24 claims. Open Payments data shows 13 records totaling $220. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $206,143 to $67,845. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $94,347 to $166,056. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,297 and ending at $4,379.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	468	2,759	$206,143
2016	343	2,367	$165,784
2017	367	2,980	$210,354
2018	360	2,191	$141,079
2019	314	2,594	$164,434
2020	192	1,033	$69,975
2021	134	960	$70,187
2022	148	1,230	$82,564
2023	142	1,360	$78,761
2024	141	1,147	$67,845

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	197	1,842	$94,347
2016	246	3,402	$305,261
2017	248	3,626	$292,226
2018	262	3,977	$296,755
2019	292	3,670	$240,323
2020	249	2,012	$122,719
2021	155	1,686	$125,782
2022	169	1,737	$115,492
2023	191	1,968	$177,679
2024	182	1,974	$166,056

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	40	$1,295
2016	13	67	$1,363
2017	N/R	22	$326
2018	N/R	16	$346
2019	N/R	35	$378
2020	N/R	N/R	N/R
2021	N/R	63	$1,783
2022	N/R	60	$1,436
2023	N/R	24	$2,863
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	80	80	$125
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	29	29	$86
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	127	510	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	39	51	$60
82962	Blood glucose (sugar) test performed by hand-held instrument	35	94	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	20	990	$19,089
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	570	$12,259
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	1,710	$1,002
Diclofenac Sodium	Diclofenac Sodium	32	997	$882
Nifedipine Er	Nifedipine	20	1,620	$811

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$220	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dustin N. Ly, MD?

Tedicare shows public-source Medicare data for Dustin N. Ly, MD (NPI 1710195268), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dustin N. Ly, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Dustin N. Ly, MD?

Dustin N. Ly, MD is linked to SUNSHINE OF MIAMI LAKES CORP (billing NPI 1861294043) in the available physician profile data.

Does Dustin N. Ly, MD have Open Payments data?

Dustin N. Ly, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.